Oncology & Cancer

Organized screening for prostate cancer does more harm than good

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm ...

Oncology & Cancer

Prostate cancer tumors' aggressiveness may be inherently fixed

A new study of prostate cancer suggests that a tumor's aggressiveness is inherently fixed at the time of its appearance, although diet, lifestyle and environmental factors may trigger progression of the disease in low-level ...

Oncology & Cancer

Prostate cancer screening: New data support watchful waiting

Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

Oncology & Cancer

New cancer imaging technology shows promise

(Medical Xpress)—A new imaging technology that combines ultrasound and laser technologies has been shown to be highly effective in identifying prostate cancer. The system, which was developed by University of Rochester ...

Oncology & Cancer

Men say they want prostate cancer test, despite risks

A survey of men age 40 to 74 found that 54 percent said that they would still opt for a popular prostate cancer screening test despite recent recommendations that the test not be performed, finds a new study in American Journal ...

Oncology & Cancer

Many men not told pros, cons of PSA testing, survey finds

(HealthDay)—Many doctors insulate their patients from the complexities surrounding the PSA test, and instead decide on their own whether to screen for prostate cancer or not, a new study finds.

page 19 from 33